Back to Archived Journals » Comparative Effectiveness Research » Volume 8

Cost-effectiveness of sunitinib as second-line treatment for gastrointestinal stromal tumor in the People’s Republic of China [Corrigendum]

Total article views   Abstract views HTML views PDF downloads Totals
1,814 Dovepress* 1,682 132+ 421 1,814
Totals 1,682 132 421 1,814
*Since 24 January 2018
+Since July 2016

View citations on Google Scholar